Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01256827 · ClinicalTrials.gov registry record

Seven Year Update of Macular Degeneration Patients

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
65
Enrollment target

NCT01256827 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01256827 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
65 participants
Enrollment target

Study Summary

The purpose is to assess long term vision outcomes and disease status in patients with age-related macular degeneration previously treated with ranibizumab as participants in the Phase 3 ANCHOR and MARINA Studies and the HORIZON Study.

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2010-12
Est. Completion 2013-04

What the Registry Record Tells You About NCT01256827

The ClinicalTrials.gov registry entry for NCT01256827 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01256827 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01256827 about?

NCT01256827 is a clinical study titled "Seven Year Update of Macular Degeneration Patients". The purpose is to assess long term vision outcomes and disease status in patients with age-related macular degeneration previously treated with ranibizumab as participants in the Phase 3 ANCHOR and MARINA Studies and the HORIZON Study.

What is the current status of trial NCT01256827?

This trial is currently completed. The enrollment target is 65 participants. The study started on 2010-12. Estimated completion is 2013-04.

Who is sponsoring clinical trial NCT01256827?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.